COWEN, NEIL M.,KASHKIN, KENNETH B.,YAMOUT, KHALED A.
申请号：
ES06847875
公开号：
ES2374963T3
申请日:
2006.12.20
申请国别(地区):
ES
年份:
2012
代理人:
摘要：
Use of a formulation according to claim 8 for the manufacture of a pharmaceutical for (i) inhibiting secretion of fasting insulin, inhibit insulin secretion stimulated by glucose, elevating energy expenditure, elevating beta fat oxidation or inhibiting hyperphagia, in an obese subject, overweight or obesity prone, comprising administering to said subject a therapeutically effective amount of said formulation (Ii) maintaining weight loss in an obese subject, overweight or obesity prone, comprising administering to said subject a therapeutically effective amount of said formulation (Iii) preventing the transition to diabetes of a prediabetic subject comprising administering to said subject a therapeutically effective amount of said formulation (Iv) preventing or treating weight gain, dyslipidemia, diabetes or impaired glucose tolerance in a patient treated with an antipsychotic drug, comprising administering to said subject a therapeutically effective amount of said formulation subject (V) treating a subject suffering from or at risk for Alzheimers disease comprising administering to said subject a therapeutically effective amount of said formulation (Vi) treating a subject suffering from hypoglycemia, comprising administering to said subject a therapeutically effective amount of said formulation or (vii) treating hyperlipoproteinemia characterized by elevated triglyceride comprising administering said formulation.Uso de una formulación de acuerdo con la reivindicación 8 para la fabricación de un producto farmacéutico para (i) inhibir la secreción de insulina en ayunas, inhibir la secreción de insulina estimulada por glucosa, elevar el gasto energético, elevar la oxidación beta de grasas o inhibir la hiperfagia, en un sujeto obeso, con sobrepeso o propenso a la obesidad, que comprende administrar a dicho sujeto una cantidad terapéuticamente eficaz de dicha formulación (ii) mantener la pérdida de peso en un sujeto obeso, con sobrepeso o propenso a la obesidad, que comp
